Columbia/HCA has selected Comdisco Medical Equipment Group asthe preferred vendor of reconditioned imaging and laboratory equipmentfor its 325 acute-care hospitals. Just what the agreement will produce in term of new businessis unclear, but Comdisco
Columbia/HCA has selected Comdisco Medical Equipment Group asthe preferred vendor of reconditioned imaging and laboratory equipmentfor its 325 acute-care hospitals.
Just what the agreement will produce in term of new businessis unclear, but Comdisco chief executive Kenneth A. Halversoninterprets the designation to mean his company is on the insidetrack for future sales.
"We think it is a strong endorsement of what we've donein the refurbished equipment business," he said.
The preferred relationship applies to refurbished MRI, CT andultrasound systems and laboratory equipment, such as blood gasanalyzers and centrifuges, according to Neal Lulofs, Comdiscosenior communications manager.
Comdisco Medical generated $100 million in revenue in fiscal1994, Lulofs said. About $22 million came from reconditioned equipmentsales, and the rest originated from Comdisco's medical equipmentleasing business.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.